Market Research Report
North America Vascular Guidewires Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||904360|
|Published||Content info||80 Pages
Delivery time: 2-3 business days
|North America Vascular Guidewires Market Forecast 2019-2027|
|Published: August 7, 2019||Content info: 80 Pages||
The North America vascular guidewires market accounted for a significant share of XX% in 2018 and is expected to grow with the 4.88% CAGR during the estimated period of 2019-2027. The market growth in the region is influenced by the trend of rising cases of chronic diseases, rapid innovation in medical devices along with favorable government policies.
The analysis of North America vascular guidewires market is studied over economies like the United States and Canada. In North American countries, the sedentary lifestyle and unhealthy food habits of people together with geriatric populace results in rising incidences of cardiovascular diseases. As a result of this, the demand for minimally invasive vascular procedures and devices increases, which influence the vascular guidewires market. Further, the favorable reimbursements framework in various countries drives the vascular guidewires market in the region. Also, due to the rising awareness among people about the vascular disorders and available treatment options, the vascular guidewires market is expected to witness mounting growth in upcoming years.
The prominent players in the market are, namely Abbott, GaltNeedleTech, Boston Scientific Corporation, Edward Lifesciences, Cook Medical LLC, Koninklijke Philips N.V., Becton Dickinson and Company, Cardinal Health Inc., B Braun Melsungen AG, and Biotronik Se & Co. KG., among others. These players focus on various strategic initiatives such as mergers & acquisitions, collaborations, and new products development to maintain a stronghold in the market.